Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STANDARD BIOTOOLS INC. Director's Dealing 2023

Apr 7, 2023

32853_dirs_2023-04-06_fe6d5ce2-4904-48d8-80ea-09dba345c738.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STANDARD BIOTOOLS INC. (LAB)
CIK: 0001162194
Period of Report: 2023-04-04

Reporting Person: Kim Hanjoon Alex (Chief Operating Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-04-04 Common Stock M 70183 Acquired 70183 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-04-04 Restricted Stock Units $ M 70183 Disposed Common Stock (70183.0) Direct

Footnotes

F1: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.

F2: Restricted Stock Units vest in four equal annual installments beginning April 4, 2023.